RVL Pharmaceuticals News - RVLP

Company Name	Stock Ticker Symbol	Market	Type
RVL Pharmaceuticals PLC	RVLP	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.0282	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.0282

more quote information »

Recent News

Date	Time	Source	Heading
1/17/2024	16:05	EDGAR2	Form 8-K - Current report
12/20/2023	16:15	EDGAR2	Form 8-K - Current report
11/27/2023	06:50	GLOBE	RVL Completes Financial Restructuring
11/16/2023	09:11	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/01/2023	16:27	EDGAR2	Form SC 13D/A - General statement of acquisition of..
10/23/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/23/2023	13:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/20/2023	17:00	EDGAR2	Form 8-K - Current report
10/20/2023	15:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/20/2023	13:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/18/2023	16:00	EDGAR2	Form 144 - Report of proposed sale of securities
10/13/2023	17:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
10/13/2023	16:15	EDGAR2	Form 8-K - Current report
10/12/2023	06:50	GLOBE	RVL Pharmaceuticals plc Announces Prepackaged Reorganization..
9/29/2023	16:05	EDGAR2	Form 8-K - Current report
9/22/2023	16:05	EDGAR2	Form 8-K - Current report
9/05/2023	16:18	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/05/2023	16:06	EDGAR2	Form 8-K - Current report
9/05/2023	07:45	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
8/31/2023	14:23	EDGAR2	Form D - Notice of Exempt Offering of Securities
8/25/2023	17:21	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/25/2023	16:17	EDGAR2	Form 8-K - Current report
8/23/2023	17:30	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/23/2023	16:05	GLOBE	RVL Pharmaceuticals plc to Present at the H.C. Wainwright..
8/18/2023	16:06	EDGAR2	Form 8-K - Current report
8/17/2023	17:06	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/17/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/17/2023	16:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/16/2023	08:00	GLOBE	RVL Pharmaceuticals plc Announces $5 Million Registered..
8/14/2023	17:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	09:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:51	EDGAR2	Form 8-K - Current report
8/14/2023	06:50	GLOBE	RVL Pharmaceuticals plc Reports Second Quarter 2023..
8/02/2023	17:00	EDGAR2	Form 8-K - Current report
8/02/2023	08:30	GLOBE	RVL Pharmaceuticals plc to Discuss Second Quarter 2023..
7/11/2023	21:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	21:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	06:50	GLOBE	RVL Pharmaceuticals plc Provides Business Update
6/15/2023	16:15	GLOBE	RVL Pharmaceuticals plc Announces Result of Proposal to..
5/11/2023	06:50	GLOBE	RVL Pharmaceuticals plc Reports First Quarter 2023 Financial..